UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro

Journal of Immunology, 2007-07, Vol.179 (2), p.854-868

2007

Volltextzugriff (PDF)

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

Blood, 2005-06, Vol.105 (12), p.4878-4884

2005

Volltextzugriff (PDF)

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism

Immunological reviews, 2002-12, Vol.190 (1), p.40-52

2002

Volltextzugriff (PDF)

HLA Alleles Determine Differences in Human Natural Killer Cell Responsiveness and Potency

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (8), p.3053-3058

2008

Volltextzugriff (PDF)

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

British journal of haematology, 2008-12, Vol.143 (5), p.641-653

2008

Volltextzugriff (PDF)

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

Clinical cancer research, 2009-12, Vol.15 (23), p.7330-7334

2009

Volltextzugriff (PDF)

Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission

Clinical cancer research, 2008-05, Vol.14 (9), p.2740-2748

2008

Volltextzugriff (PDF)

Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

The Journal of immunology (1950), 2003-12, Vol.171 (12), p.6891-6899

2003

Volltextzugriff (PDF)

Survey of Naturally Occurring CD4+T Cell Responses against NY-ESO-1 in Cancer Patients: Correlation with Antibody Responses

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (15), p.8862-8867

2003

Volltextzugriff (PDF)

Monitoring CD8 T Cell Responses to NY-ESO-1: Correlation of Humoral and Cellular Immune Responses

Proceedings of the National Academy of Sciences - PNAS, 2000-04, Vol.97 (9), p.4760-4765

2000

Volltextzugriff (PDF)

Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses

Immunological reviews, 2002-11, Vol.189 (1), p.161-178

2002

Volltextzugriff (PDF)

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

Blood, 2001-11, Vol.98 (10), p.2922-2929

2001

Volltextzugriff (PDF)

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

Clinical cancer research, 2009-07, Vol.15 (13), p.4467-4474

2009

Volltextzugriff (PDF)

Src-Induced Activation of Inducible T Cell Kinase (ITK) Requires Phosphatidylinositol 3-Kinase Activity and the Pleckstrin Homology Domain of Inducible T Cell Kinase

Proceedings of the National Academy of Sciences - PNAS, 1997-10, Vol.94 (21), p.11227-11232

1997

Volltextzugriff (PDF)

HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine

Clinical cancer research, 2009-01, Vol.15 (1), p.299-306

2009

Volltextzugriff (PDF)

HLA-C–Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1

The New England journal of medicine, 2012-08, Vol.367 (9), p.805-816

2012

Volltextzugriff (PDF)

Strategy for Monitoring T Cell Responses to NY-ESO-1 in Patients with Any HLA Class I Allele

Proceedings of the National Academy of Sciences - PNAS, 2000-09, Vol.97 (20), p.10917-10922

2000

Volltextzugriff (PDF)

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I

Immunity (Cambridge, Mass.), 2016-08, Vol.45 (2), p.280-291

2016

Volltextzugriff (PDF)

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

The Journal of clinical investigation, 2012-09, Vol.122 (9), p.3260-3270

2012

Volltextzugriff (PDF)

Nomenclature for factors of the HLA system, 2002

Human immunology, 2002-12, Vol.63 (12), p.1213-1268

2002

Volltextzugriff (PDF)

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

Blood, 2010-04, Vol.115 (15), p.3162-3165

2010

Volltextzugriff (PDF)

KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy

Biology of blood and marrow transplantation, 2006-08, Vol.12 (8), p.828-836

2006

Volltextzugriff (PDF)

The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry

Biology of blood and marrow transplantation, 2006-08, Vol.12 (8), p.876-884

2006

Volltextzugriff (PDF)

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

The Journal of immunology (1950), 2013-05, Vol.190 (9), p.4650-4660

2013

Volltextzugriff (PDF)

LCK-Phosphorylated Human Killer Cell-Inhibitory Receptors Recruit and Activate Phosphatidylinositol 3-Kinase

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.11810-11815

1998

Volltextzugriff (PDF)

1 – 25 von 349

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(299)
Mit Volltextzugriff
(272)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(217)
Science & Technology
(203)
Life Sciences & Biomedicine
(173)
Immunology
(103)
Biological And Medical Sciences
(76)
Male
(66)
Female
(64)
Hla Antigens - Genetics
(57)
Animals
(44)
Fundamental And Applied Biological Sciences. Psychology
(44)
Alleles
(39)
Fundamental Immunology
(36)
Medical Sciences
(32)
Lymphocyte Activation
(30)
T-Lymphocytes - Immunology
(30)
Adult
(29)
Killer Cells, Natural - Immunology
(28)
Antigens
(26)
Molecular Sequence Data
(26)
Amino Acid Sequence
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism

HLA Alleles Determine Differences in Human Natural Killer Cell Responsiveness and Potency

Infusion of haplo‐identical killer immunoglobulin‐like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation

KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma

Safety and Immunogenicity Study of NY-ESO-1b Peptide and Montanide ISA-51 Vaccination of Patients with Epithelial Ovarian Cancer in High-Risk First Remission

Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma

Survey of Naturally Occurring CD4+T Cell Responses against NY-ESO-1 in Cancer Patients: Correlation with Antibody Responses

Monitoring CD8 T Cell Responses to NY-ESO-1: Correlation of Humoral and Cellular Immune Responses

Visualization of signaling pathways and cortical cytoskeleton in cytolytic and noncytolytic natural killer cell immune synapses

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

Vaccination with Recombinant NY-ESO-1 Protein Elicits Immunodominant HLA-DR52b-restricted CD4+ T Cell Responses with a Conserved T Cell Receptor Repertoire

Src-Induced Activation of Inducible T Cell Kinase (ITK) Requires Phosphatidylinositol 3-Kinase Activity and the Pleckstrin Homology Domain of Inducible T Cell Kinase

HLA Class I–Associated Immunodominance Affects CTL Responsiveness to an ESO Recombinant Protein Tumor Antigen Vaccine

HLA-C–Dependent Prevention of Leukemia Relapse by Donor Activating KIR2DS1

Strategy for Monitoring T Cell Responses to NY-ESO-1 in Patients with Any HLA Class I Allele

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

Nomenclature for factors of the HLA system, 2002

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

KIR Ligands and Prediction of Relapse after Unrelated Donor Hematopoietic Cell Transplantation for Hematologic Malignancy

The Effect of KIR Ligand Incompatibility on the Outcome of Unrelated Donor Transplantation: A Report from the Center for International Blood and Marrow Transplant Research, the European Blood and Marrow Transplant Registry, and the Dutch Registry

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand

LCK-Phosphorylated Human Killer Cell-Inhibitory Receptors Recruit and Activate Phosphatidylinositol 3-Kinase

Suchergebnisse filtern